Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02273375
Recruitment Status : Active, not recruiting
First Posted : October 24, 2014
Last Update Posted : February 2, 2021
Sponsor:
Collaborators:
Intergroupe Francophone de Cancerologie Thoracique (IFCT)
Australasian Lung Cancer Trials Group
National Health and Medical Research Council, Australia
National Cancer Institute (NCI), Naples
Central and Eastern European Oncology Group
Dutch Society of Physicians for Pulmonology and Tuberculosis
Korean Cancer Study Group
Fundación GECP
West Japan Oncology Group (WJOG)
Chinese Thoracic Oncology Group
Information provided by (Responsible Party):
Canadian Cancer Trials Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 31, 2023
Estimated Study Completion Date : January 31, 2024